Previous Close | 42.95 |
Open | 43.24 |
Bid | 40.76 x 100 |
Ask | 40.91 x 100 |
Day's Range | 40.80 - 44.61 |
52 Week Range | 18.00 - 53.92 |
Volume | |
Avg. Volume | 1,113,291 |
Market Cap | 3.029B |
Beta (5Y Monthly) | 0.84 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Insights into SWTX's robust Q1 performance, strategic initiatives, and forward-looking financial health.
R&D Expenses: R&D expenses increased to $150.5 million in 2023, reflecting investment in clinical trials and drug development. Net Loss: Net loss widened to $325.1 million in 2023, with a loss per share of $5.15.